Recognizing and Managing Polypharmacy in Advanced Illness
| Autor: | Mary Lynn McPherson, Shaida Talebreza |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Drug-Related Side Effects and Adverse Reactions Health Services for the Aged Critical Illness Health Personnel Psychological intervention Inappropriate Prescribing 03 medical and health sciences Deprescriptions 0302 clinical medicine Patient-Centered Care Intervention (counseling) Health care Diabetes Mellitus Humans Medicine Vulnerable population 030212 general & internal medicine Aged Aged 80 and over Polypharmacy Diphosphonates business.industry Communication General Medicine Middle Aged Family medicine Female Cholinesterase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Communication skills business 030217 neurology & neurosurgery |
| Zdroj: | Medical Clinics of North America. 104:405-413 |
| ISSN: | 0025-7125 |
| DOI: | 10.1016/j.mcna.2019.12.003 |
| Popis: | Older adults, particularly those late in life, are at higher risk for medication misadventure, yet bear the burden of increasing polypharmacy. It is incumbent on practitioners who care for this vulnerable population to use one or more approaches to deprescribe medications that impose a greater burden than benefit, including medically futile medications. It is essential that health care providers use compassionate communication skills when explaining these interventions with patients and families, pointing out that this is a positive, patient-centric intervention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|